The Food and Drug Administration approved Kisunla on Tuesday for mild or early cases of dementia, only the second drug shown to delay cognitive decline
Daily Express :: Health Feed
The Food and Drug Administration approved Kisunla on Tuesday for mild or early cases of dementia, only the second drug shown to delay cognitive decline
Daily Express :: Health Feed